Bedfont® sponsors IFE golf day to raise vital funds for the mental health charity Young Minds.

Bedfont® Scientific Limited, a local medical breath analysis device manufacturer, is thrilled to announce its sponsorship and participation in a local charity golf day hosted by IFE Group, raising vital funds for Young Minds, a leading UK charity dedicated to fighting for the mental health of children and young people.

Bedfont® has a strong passion for wellbeing and mental health, and is proud to support a cause that aligns with its values of compassion, collaboration, and positive social impact. Teeing off on Wednesday, 2nd July at 10:00 a.m., the IFE golf day will be held at Ashford Manor Golf Club, bringing together local businesses and featuring friendly competitions and fundraising throughout the day. The money raised at the event will go directly to Young Minds, supporting their mission to ensure that no young person feels alone with their mental health.

« We are honoured to be part of this meaningful initiative,” said Jason Smith, CEO at Bedfont®. “At Bedfont®, we believe in the power of community and the importance of supporting mental health, especially among young people. Partnering with IFE Global Digital Logistics for this event is an opportunity to make a meaningful difference.”

IFE Group is a leading logistics supplier, specialising in sea, air, road, and rail freight, with a strong commitment to making a difference in the local community through charity fundraising. Its charity golf day offers a chance to participate in a friendly golf competition, complete with a sit-down meal and prize giving, while raising money for a fantastic cause. For more information about the IFE Group, please visit the website.

“The IFE Group is delighted to be aligned with a charity doing such important work in what we feel is a vital area, the mental health of the ‘next generation’.” Said Chris Darbin, CEO at IFE Group. “The charity is close to our hearts, and as we embrace youth into our organisation, we recognise the ever-changing effect the world has on the ‘Young Minds’ of today and how important it is to ‘give back’. We are honoured that so many of our loyal clients and suppliers are joining us for a day of FUNdraising for our special charity! We look forward to seeing everyone there and making the day a success!”

Young Minds is a leading UK charity dedicated to improving mental health among young people. Their services support young people struggling with their mental health as well as their parents and carers. To fulfil their vision of a world where no young person feels alone with their mental health, it relies on the support and generosity of the public and events like the IFE golf day make a huge difference. For more information on Young Minds and their impact on young people’s mental health, visit their website here.

For updates on the event, be sure to follow Bedfont® Scientific on social media, and to find out more about Bedfont®, visit the website here.

Electromed Corporation completes registration for piCO™ CO device in Pakistan

Bedfont® Scientific Limited, an innovative med-tech company and world leaders in breath analysis, has partnered with Electromed Corporation. Electromed, an intensive respiratory and sleep care equipment business, has recently completed registration for the piCO™ Smokerlyzer® CO device, bringing the innovative technology of CO monitoring for smoking cessation to Pakistan.

Monin Uddin, the NObreath® and Smokerlyzer® Product Manager at Electromed, said, “This achievement marks a significant milestone in expanding access to innovative respiratory diagnostics in the region. We’re excited to announce that the Fractional exhaled Nitric Oxide (FeNO) registration for NObreath® is imminent, further enhancing our product offerings. Electromed is fully engaged in promoting Smokerlyzer® and NObreath® across Pakistan, ensuring healthcare professionals have the tools they need to deliver exceptional patient care”.

Smoking cessation is notoriously difficult, but monitoring CO levels during a quit attempt allows patients to see their CO levels in real-time, giving them the motivation to quit. CO is a colourless, odourless gas that is found in tobacco smoke, and high levels of CO can lead to various health complications and smoking-related diseases, such as cancer, breathing problems, chronic respiratory conditions, heart disease, stroke and blood circulation problems1. The piCO™ is a breath CO device that enables patients to monitor their CO levels during a quit smoking attempt.

Jason Smith, CEO at Bedfont®, comments, “We are thrilled to partner with Electromed Corporation as they complete registration for the piCO™ Smokerlyzer® CO device. Their strong regional presence and proven track record makes them an ideal collaborator as we expand access to our innovative technology. This partnership marks an important step in our mission to provide cutting-edge breath analysis medical products worldwide.”

Electromed Corporation is an ideal collaboration, aligning with Bedfont’s core values of providing excellent patient-centred care and innovation. This partnership will ensure the innovative technology of the piCO™ Smokerlyzer® is available across Pakistan, ultimately improving smoking cessation outcomes in the region.

For more information on the Smokerlyzer® range of CO devices, visit the website here.

References

  1. National Institute for Health and Care Excellence. What Are the Harms Caused by smoking? [Internet]. NICE. 2024. Available from: https://cks.nice.org.uk/topics/smoking-cessation/background-information/harms-caused-by-smoking/

During Love Your Lungs Week, we highlight how breath analysis technology transforms our understanding, diagnosis, and protection of lung health. Non-invasive tools like the Smokerlyzer® Carbon Monoxide (CO) monitoring device and the NObreath® Fractional exhaled Nitric Oxide (FeNO) device turn a simple exhale into powerful clinical data.

Love Your Lungs Week, launched in 2019 by the British Lung Foundation (Now Asthma + Lung UK), is an annual health awareness campaign observed in the UK. The campaign aims to raise awareness about lung health and the importance of good lung health1.

With over 8 million deaths per year due to tobacco use2 and 455,000 asthma-related deaths3, more needs to be done to encourage better lung health. There are various challenges to aiding smoking cessation and improving asthma care and management, and this blog is going to look at how a simple breath test can help.

When we exhale, we breathe out various gases that have been absorbed into our bloodstream for various reasons. Some of these gases are found naturally in our exhaled breath. However, elevated levels of certain gases can cause harm or indicate inflammation in the airways.

Carbon Monoxide (CO)

CO is a colourless, odourless gas found in vehicle exhaust fumes, fires, and tobacco smoke. When CO is inhaled from tobacco smoke, it binds to haemoglobin in red blood cells to form carboxyhaemoglobin (COHb), which reduces the blood’s ability to transport oxygen to organs4. This can then lead to a variety of health complications, such as4: Cancer, Breathing and chronic respiratory conditions, Heart disease, stroke and blood circulation problems and Diabetes.

Nitric Oxide (NO)

NO is a gas that is naturally present in exhaled breath. In healthy lungs, it plays a normal role in immune defence and regulating airway function. However, increased NO levels can indicate airway inflammation, which is commonly found in patients with asthma5. If airway inflammation is untreated, it can contribute to several health risks, such as6:

  • Airway and lung damage,
  • Increased risk of infection,
  • Severe asthma exacerbations.

Monitoring CO levels for a quit smoking attempt

CO monitoring devices, such as the Smokerlyzer®, are useful tools for aiding smoking cessation. By providing real-time feedback, the Smokerlyzer® allows users to see their CO levels decreasing, giving them that motivational push to succeed with their quit attempt.

Monitoring airway inflammation for asthma management

A FeNO test is a quick, easy, and non-invasive way to evaluate airway inflammation. The NObreath® device measures FeNO levels to evaluate airway inflammation to aid in asthma diagnosis and management. By incorporating FeNO testing into the asthma care pathway, healthcare professionals can monitor FeNO levels and guide treatment decisions.

Various studies and reports have highlighted the importance of CO monitoring devices for smoking cessation and FeNO testing for asthma care and management.

  • CO monitoring devices

A study by Beard and West (2012) on the effectiveness of personal Carbon Monoxide monitoring found that out of 10 smokers, “7 of the smokers reported that they felt as though the devices had reduced their cigarette consumption… 6 smokers reported a lower nicotine dependency relative to baseline. Over the 6 weeks, there appeared to be a significant decline in the number of cigarettes smoked per day7”.

  • FeNO testing

In a recent study by Lewis et al (2025), on the qualitative insights into planning implementation of FeNO-guided asthma management in primary care found that participants, comprising policymakers, healthcare managers, NHS commissioners, healthcare professionals with extended roles, patients, and patient advocates, acknowledged that FeNO-informed asthma management could enhance care by providing objective measures of airway inflammation, aiding in personalised treatment8.

Love Your Lungs Week is dedicated to raising awareness of lung health and encouraging people to take better care of their respiratory health. This week is the perfect time to take control of lung health. A simple breath test with devices like the Smokerlyzer® and NObreath® can motivate a quit smoking attempt or ensure that someone with asthma can live a normal, unrestricted life with their condition well-controlled.

To learn more about the Smokerlyzer® and NObreath®, visit the website here.

References

  1. Love Your Lungs Week [Internet]. Asthma + Lung UK. 2025 [cited 2025 May 19]. Available from: https://www.asthmaandlung.org.uk/love-your-lungs-week
  2. Dogar O, Amer Nordin AS, Barnoya J, Ayo-Yusuf O, Bullen C. Tobacco Cessation Research in Low- and Middle-Income Countries: A commentary on Challenges, Innovations and Opportunities. Nicotine and Tobacco Research [Internet]. 2025 Jan 22 [cited 2025 Jan 25]; Available from: https://academic.oup.com/ntr/advance-article-abstract/doi/10.1093/ntr/ntaf019/7972768?redirectedFrom=PDF&casa_token=TetwwA-qTqMAAAAA:aiUt-AK625v2nZKcN2MGbrWVOaPNqm8wdog5APMKjDkVjjTyTmU6myO6F_L3x585rvPTLCSxIAxkp
  3. World Health Organization. Asthma [Internet]. World Health Organization. World Health Organization; 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/asthma
  4. UK Health Security Agency. Carbon monoxide: general information [Internet]. GOV.UK. 2022. Available from: https://www.gov.uk/government/publications/carbon-monoxide-properties-incident-management-and-toxicology/carbon-monoxide-general-information
  5. ‌Ritz T, Salsman ML, Young DA, Lippert AR, Khan DA, Ginty AT. Boosting nitric oxide in stress and respiratory infection: Potential relevance for asthma and COVID-19. Brain, Behavior, & Immunity – Health [Internet]. 2021 Jul [cited 2023 Mar 2];14:100255. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019595/
  6. Asthma.com. Effects of Asthma Over Time | Asthma.com [Internet]. www.asthma.com. 2021. Available from: https://www.asthma.com/treating-asthma/effects-of-asthma/
  7. ‌Pilot Study of the Use of Personal Carbon Monoxide Monitoring to Achieve Radical Smoking Reduction. Journal of Smoking Cessation. Emma Beard and Robert West (2012). [cited on 31/5/24] Available from https://web.archive.org/web/20180721211143id_/https://www.cambridge.org/core/services/aop-cambridge-core/content/view/0BAC2289E42E9C31C892D54BF7980237/S1834261212000011a.pdf/div-class-title-pilot-study-of-the-use-of-personal-carbon-monoxide-monitoring-to-achieve-radical-smoking-reduction-div.pdf

 Lewis G, Morton K, Santillo M, Yardley L, Wang K, Ainsworth B, et al. Qualitative insights into planning implementation of FeNO-guided asthma management in primary care. npj Primary Care Respiratory Medicine. 2025 Mar 20;35(1). Available from https://www.nature.com/articles/s41533-025-00418-w

With wellbeing embedded into its culture, Bedfont® leads by example this World Wellbeing Week.

World Wellbeing Week is a global awareness event recognised annually during the last week of June. Launched in 2019 by Wellbeing World, the event promotes physical, mental, emotional, social, and environmental wellbeing in workplaces, communities and homes. Bedfont® Scientific Limited, a medical breath analysis device manufacturing company with over 48 years of experience, actively promotes workplace wellbeing and welcomes this year’s World Wellbeing Week.

With an estimated 776,000 workers in Great Britain suffering from work-related stress, depression, or anxiety in 2023/241, companies must do better to ensure employee wellbeing. Bedfont® has a dedicated team of Wellbeing Warriors who work tirelessly to ensure a healthy work/life balance for all employees. Various activities and events are held throughout the year for staff, such as healthy breakfasts and lunches, stress-busting activities, active challenges, and weekly walks, all designed to encourage staff to step away from their desks and take a break.

Claire Dadswell, Wellbeing Manager at Bedfont®, comments, “Prioritising wellbeing in the workplace is not just a moral responsibility, it’s a strategic driver of performance and culture. Employees who feel supported, healthy, and valued are more engaged, motivated, and resilient. However, the true impact of any wellbeing initiative depends on leadership. When the senior management team actively supports and champions wellbeing, it sends a powerful message. That commitment filters through every company level, creating a culture where care, productivity, and purpose thrive together.”

Bedfont’s dedicated Wellbeing Garden, which opened in 2023, offers staff a tranquil space to take time out, relax, and reflect. The wellbeing room is another space for staff to take time out, play games, or use the red light therapy machine and CELLER8® Pulsed Electromagnetic Field (PEMF) device. Red light therapy and PEMF therapy support wellbeing by enhancing cellular function, reducing inflammation, and promoting relaxation, recovery, and overall energy balance2.

« At Bedfont®, wellbeing is more than a policy, it’s a daily priority.” Said Jason Smith, CEO at Bedfont®. “We genuinely care about how our people feel, and that’s why we’ve introduced things like red light and PEMF therapy, a Wellbeing Garden, and flexible work options. When our team feels supported and balanced, they can perform at their best, individually and collectively. »

Earlier this month, the most recent team-building event saw the Bedfont® office close for the afternoon, and staff were treated to various activities and relaxation at St Andrews Lake. This is just one of many initiatives arranged by the Wellbeing Warriors, which give staff a much-needed wellbeing boost.

By embedding wellbeing into its culture and daily operations, Bedfont® has seen the positive impact, and other organisations can benefit from a similar approach. For more information and to follow Bedfont’s wellbeing initiatives, find them on social media or visit www.bedfont.com.

References

  1. BreadcrumbList [Internet]. Priory. 2025 [cited 2025 May 8]. Available from: https://www.priorygroup.com/mental-health/stress-treatment/stress-statistics?
  2. Martin DS. What Is PEMF Therapy? 5 Things You Should Know [Internet]. The Joint Replacement Center of Scottsdale. 2024. Available from: https://jointreplacementcenterscottsdale.com/blog/what-is-pemf-therapy/

Teams from Bedfont® and Perrys Chartered Accountants to go head-to-head in fundraising event.

Bedfont® Scientific Limited, a local MedTech company with over 48 years of knowledge and expertise in designing and manufacturing medical breath analysis devices, is proud to participate in a charity football match on Saturday, 14th June, to raise funds for Communigrow, a sustainable food education charity based in East Malling. The event, hosted by Perrys Chartered Accountants, will take place from 12:00 p.m. to 4:00 p.m. at the Princes Park Community Pitch at Dartford Football Club.

Communigrow is a charity dedicated to teaching children, young people, and adults how to grow fresh food using chemical-free, sustainable methods. It supports the local community by donating a portion of its produce to local food projects and providing veg boxes for purchase. To learn more about Communigrow and their outstanding work, visit their website here.

“We’re proud to support Communigrow and the incredible work they do in our community,” said Jason Smith, CEO of Bedfont®. “By entering a team to take part in this charity match, we hope to make a meaningful contribution while also bringing our colleagues together for a great cause. It’s a fantastic opportunity to give back and have fun doing it.”

As Communigrow’s mission focuses on sustainability and wellbeing, Bedfont® was thrilled to be invited to share in those values and take part in a friendly match. The game will bring together employees from both Bedfont® and Perrys Chartered Accountants for some friendly competition.

Steve Hale, Managing Partner at Perrys Chartered Accountants, comments, “Perrys is proud to support Communigrow by hosting this charity football match against Bedfont® Scientific. With Perrys FC football skills on display and support from family and friends, we aim to raise over £1,000 for their community work. A special thanks to our Perrys Historic Dockyard branch for organising.”

Perrys Chartered Accountants is a well-established accountancy firm, with several branches across the South East. Perrys has a strong connection in the local community, sponsoring local charities and events. This charity football match aims to raise awareness of the work Communigrow do and raise vital funds so their work can continue. To find out more about Perrys Chartered Accounts, visit the website here.

Members of the public are invited to attend the event and show their support, with refreshments and donation opportunities available throughout the day. The event is cash only, and all proceeds from the day will go directly to Communigrow.

To learn more about Bedfont®, please visit our website here.

Back to top